本页面由Tiger Trade Technology Pte. Ltd.提供服务

Editas Medicine, Inc.

2.75
-0.1500-5.17%
盘后:2.750.00000.00%19:37 EDT
成交量:129.75万
成交额:362.81万
市值:4.21亿
市盈率:-3.76
高:2.91
开:2.90
低:2.73
收:2.90
52周最高:4.33
52周最低:1.66
股本:1.53亿
流通股本:1.15亿
量比:0.37
换手率:1.13%
股息:- -
股息率:- -
每股收益(TTM):-0.7307
每股收益(LYR):-1.8036
净资产收益率:-118.82%
总资产收益率:-23.29%
市净率:4.00
市盈率(LYR):-1.52

数据加载中...

2026/10/08

重要事件披露

Form 8-K - Current report
2026/09/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/05

重要事件披露

Form 8-K - Current report
2026/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/18

重要事件披露

Form 8-K - Current report
2026/06/04

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/04

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/02

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/14

重要事件披露

Form 8-K - Current report
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report